| Application |
Material |
Title |
| Therapeutic |
Oncology |
| Chemical |
AC-05
Novel VEGFR-3 Antagonists for Cancer Treatment |
| Chemical |
AC-03
Novel Furoquinoline Compounds with Anti-mitotic Properties |
| Chemical |
AC-10
Novel Flavonoid Derivates for Cancer Treatment |
| Chemical |
AC-04
Novel Anti-mitotic Agent for Cancer Treatment |
| Gene Therapy |
GM-01
Combination of Gene Therapy and Immunotherapy for the Treatment of Orthotropic Liver Tumors |
| Neuro- degenerative Disease |
Chemical, Botanic Extract |
NS-01
Botanic Extract and Leads for the Treatments on Huntington's Disease |
| Pain Control |
Chemical |
SDE, YP8000
Novel Nalbuphine as the Long-Acting Drug and Prodrug for Pain Relief |
| Diagnostic |
Cancer Prognosis |
Nucleic acids |
GM-02
microRNA Biomarkers for Survival in Prognostic Non-Small Cell Lung Cancer (NSCLC) Patients |
| Infectious Disease |
Nucleic acids |
GM-03
magA, A PCR-based in vitro diagnostic marker for early detection of liver abscess associated with K. pneumoniae infection |
| Research Tool |
Biological |
GM-04
HypC1I, Novel Isoschizomer of Restriction Endonuclease BccI |
| Bio-array |
BA-01
3-in-1 Microfluidic Platform and Analytic System for Bio-assays |
M-W